What are the typical cerebrospinal fluid (CSF) findings in neurosyphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cerebrospinal Fluid Findings in Neurosyphilis

The diagnosis of neurosyphilis requires a combination of CSF abnormalities including elevated white blood cell count (>5 WBC/mm³), elevated protein (>45 mg/dL), and reactive CSF-VDRL test, along with clinical assessment and serum serologies. 1

Key CSF Findings

CSF Serological Tests

  • CSF-VDRL:

    • Gold standard serological test for CSF
    • Sensitivity: 49-87.5%
    • Specificity: 74-100%
    • When reactive (in absence of blood contamination), considered diagnostic of neurosyphilis
    • May be nonreactive even when neurosyphilis is present 1
  • CSF-RPR:

    • Sensitivity: 51-82%
    • Specificity: 82-100%
    • May be less sensitive than CSF-VDRL 1
  • CSF-TRUST:

    • Sensitivity: 76.2%
    • Specificity: 93.1% 1
  • CSF-FTA-ABS:

    • Less specific (more false positives) than CSF-VDRL
    • Highly sensitive
    • Some specialists believe a negative CSF-FTA-ABS excludes neurosyphilis 1
    • Sensitivity reported as high as 90% 2

CSF Cellular and Biochemical Abnormalities

  • CSF WBC Count:

    • Usually elevated (>5 WBC/mm³) in active neurosyphilis
    • Sensitive measure of treatment effectiveness
    • Lymphocytic-plasmocytic cell reaction 1, 3
    • Present in 42% of patients with high serum VDRL titers (≥1:32) 4
  • CSF Protein:

    • Typically elevated (>45 mg/dL)
    • Present in 39% of patients with high serum VDRL titers (≥1:32) 4

Diagnostic Challenges

  1. No Single Definitive Test:

    • No test alone can diagnose neurosyphilis
    • Diagnosis relies on combinations of:
      • Reactive serologic tests
      • CSF abnormalities
      • Clinical manifestations 1
  2. Sensitivity Issues:

    • CSF-VDRL is highly specific but insensitive
    • In ocular syphilis, CSF-VDRL sensitivity is <50%
    • In otic syphilis, CSF-VDRL sensitivity is poor (<10%) 1
  3. False Positives/Negatives:

    • False positive CSF-VDRL can occur with:
      • CNS malignancy
      • Blood contamination during lumbar puncture 1
    • False negative results can occur despite active infection 5
  4. HIV Considerations:

    • HIV infection itself may cause mild CSF pleocytosis (5-15 cells/μL)
    • Makes neurosyphilis diagnosis more challenging in HIV-infected patients 1

Advanced Diagnostic Indices

  • TPHA Index:

    • Measures intrathecal production of treponemal antibodies
    • Specificity: 100%, Sensitivity: 98.3% 2
  • CSF-CXCL13 Concentration:

    • Newer biomarker with higher sensitivity (78-83%)
    • Specificity: 76-81%
    • May help diagnose neurosyphilis when CSF-VDRL is nonreactive 6

Clinical Correlation

The interpretation of CSF findings must always be correlated with clinical presentation and serum serologies. Patients with high serum RPR/VDRL titers (>1:32) have higher risk of neurosyphilis, especially those with HIV 1, 4.

Pitfalls to Avoid

  1. Relying on a single test: No single test has sufficient sensitivity and specificity to rule in or rule out neurosyphilis.

  2. Ignoring clinical context: CSF findings must be interpreted in the context of clinical symptoms and serum serology.

  3. Missing asymptomatic neurosyphilis: CSF examination should be considered in high-risk patients (high serum titers, HIV infection) even without neurological symptoms.

  4. Traumatic lumbar puncture: Blood contamination can cause false-positive CSF-VDRL in patients with high serum titers.

  5. Overlooking ocular/otic syphilis: These conditions may have normal CSF findings in up to 40% of cases despite active infection 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.